WHO ICTRP trial

Alfentanil combined with dexmedetomidine for painless conscious sedation in…

ChiCTR2500096208 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500096208
Public title Alfentanil combined with dexmedetomidine for painless conscious sedation in outpatient gastroscopy in obese patients
Scientific title Alfentanil combined with dexmedetomidine for painless conscious sedation in outpatient gastroscopy in obese patients
Primary sponsor Department of Anesthesiology, Shiyan People's Hospital (People's Hospital Affiliated to Hubei Medical College)
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 0
Countries China
Conditions Anesthesia for obese patients
Interventions experimental group:Dexmedetomidine 0.6 µg/kg was pumped intravenously for 10 min, and 6 µg/kg alfentanil (Yichang Renfu Pharmaceutical) was injected intravenously for conscious sedation.;control subjects:Intravenous 6 µg/kg alfentanil…
Registration date Jan 20, 2025
Target size experimental group:60;control subjects:60
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations